Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT05043701
What this trial is testing

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Oslo University Hospital 15
Not applicableStudy completedNCT05186064
What this trial is testing

Glioblastoma Targeted Treatment Option Maximization by WGS

Who this might be right for
Glioblastoma
UMC Utrecht 164
Testing effectiveness (Phase 2)Study completedNCT00657267
What this trial is testing

Dose-Intense Temozolomide in Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Patrick Y. Wen, MD 58
Not applicableWithdrawnNCT05410301
What this trial is testing

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Varun Monga, MD
Large-scale testing (Phase 3)WithdrawnNCT00083447
What this trial is testing

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Xenova Biomedix 323
Testing effectiveness (Phase 2)Study completedNCT00006093
What this trial is testing

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT03277638
What this trial is testing

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Who this might be right for
Glioblastoma, Adult
Case Comprehensive Cancer Center 32
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Early research (Phase 1)Study completedNCT01475006
What this trial is testing

AMG 595 First-in-Human in Recurrent Gliomas

Who this might be right for
Advanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme
Amgen 32
Early research (Phase 1)Study completedNCT01390571
What this trial is testing

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT07349693
What this trial is testing

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
Everfront Biotech Co., Ltd. 175
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Testing effectiveness (Phase 2)UnknownNCT06279767
What this trial is testing

Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaCancerTemozolomide
The First Affiliated Hospital with Nanjing Medical University 27
Not applicableNo Longer AvailableNCT05936216
What this trial is testing

TVI-Brain-1 in Expanded Access Patient

Who this might be right for
Recurrent Glioblastoma
TVAX Biomedical
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT03128047
What this trial is testing

HUMC 1612: Optune NovoTTF-200A System

Who this might be right for
High Grade GliomaEpendymoma
Hackensack Meridian Health 7
Testing effectiveness (Phase 2)Study completedNCT00112736
What this trial is testing

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+8 more
National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Study completedNCT00238264
What this trial is testing

Radiation Therapy in Treating Young Patients With Gliomas

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 92
Not applicableStudy completedNCT05735171
What this trial is testing

Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

Who this might be right for
Glioblastoma
Hospital del Rio Hortega 20
Early research (Phase 1)Study completedNCT01967758
What this trial is testing

Phase I Study of Safety and Immunogenicity of ADU-623

Who this might be right for
Astrocytic TumorsGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
Providence Health & Services 11
Next Page